Why pharma giant Roche is putting German investments on hold

What happened: Roche said it has put all future investment decisions in Germany on hold, with its Germany head citing political decisions that destroyed trust in the pharmaceutical sector. Key numbers: German lawmakers in July passed a bill raising the rebate on most branded medicines to 15.5% from next year, up from 7%. Why it matters: The announcement came as Berlin hosted an investment summit. Siemens head Roland Busch said it signals companies will invest elsewhere if conditions in Germany are not right.

Roche said it has put all future investment decisions in Germany on hold, with its Germany head citing political decisions that destroyed trust in the pharmaceutical sector.

The announcement came as Berlin hosted an investment summit. Siemens head Roland Busch said it signals companies will invest elsewhere if conditions in Germany are not right.